.omega.-amino-.alpha.-phenylalkanonitrile derivatives

.OMEGA.-Cyano-1, .OMEGA.-diphenyl-azaalkane derivatives, their p

.omega.-Dialkylalkanoic acid derivatives used to induce antianox

.omega.-Halo-PGI.sub.2 analogues

.omega.-Nor-cycloalkyl-13,14-dehydro-prostaglandins

.omega.-Nor-cycloalkyl-13,14-dehydro-prostaglandins and process

.omega.-[2-(N-Lower alkyl-benzamido)-phenyl]-alkanoic acids, the

.omega.-[2-(phosphonoalkyl)phenyl]-2-aminoalkanoic acids as anta

.omega.-[2-(tetrazolylalkyl)cyclohexyl]-2-aminoalkanoic acids as

.omega.-[2-(tetrazolylalkyl)cyclohexyl]-2-aminoalkanoic acids as

.omega.9-unsaturated fatty acid compositions for preventing or a

.omicron.-Chlorobenzamidoxime as an anti-inflammatory agent

.rho.-heteroatom-substituted phenols and uses thereof

.sigma.-2 receptors as biomarkers of tumor cell proliferation

.sup.125 I and .sup.131 I labeled phospholipids

.sup.13 C Isotopomer analyses in intact tissue using (.sup.13 C)

.sup.18 F-4-Fluoroantipyrine

.sup.19 F labelled antibodies and fragments thereof as NMR imagi

.sup.19 F poly aza macrocyclic MRI contrast medium

.sup.75 Se and .sup.123m Te Compounds for fat resorption tests